Funder
National Institute on Minority Health and Health Disparities
University of Texas Health Science Center at San Antonio
Genentech
Novartis
Eli Lilly and Company
Pfizer
Gilead Sciences
AstraZeneca
University of Texas MD Anderson Cancer Center
Publisher
Springer International Publishing
Reference66 articles.
1. Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457–80.
2. Klotz L. Active surveillance for prostate cancer: a review. Curr Urol Rep. 2010;11(3):165–71.
3. Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol. 2011;29(16):2185–90.
4. van den Bergh RC, Essink-Bot ML, Roobol MJ, Wolters T, Schroder FH, Bangma CH, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer. 2009;115(17):3868–78.
5. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide [database on the Internet]. International Agency for Research on Cancer. 2013. Accessed Apr 2018.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献